Biliary Tract Cancer - 80 Studies Found

Completed : Second Line Therapy in Advanced Biliary Tract Cancer
: Biliary Tract Cancer
: 2012-02-03
:
  • Drug: capecitabine and mitomycin

Recruiting : Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers
: Biliary Tract Cancer
: 2017-05-05
: Drug: Apatinib Apatinib 500mg, po, qd, every 4 weeks.
Active, not recruiting : Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer Who Failed Gemcitabine-based Combination Chemotherapy
: Biliary Tract Cancer
: 2015-10-16
: Drug: Lenvatinib Lenvatinib will be administered orally once daily in 28-day cycles. Participants will b
Withdrawn : Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers
: Biliary Tract Cancer
: 2016-03-23
: Drug: Irinotecan & Capecitabine Irinotecan will be administered at infusion room over 60 minutes. Ca
Completed : Vessel Resection and Reconstruction of Biliary Tract Cancers
: Biliary Tract Cancer
: 2013-05-14
Completed : Case Series Study of Biliary Tract Cancer Patients in Japan
: Biliary Tract Cancer
: 2011-01-03
Completed : A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China
: Biliary Tract Cancer
: 2006-06-19
Active, not recruiting : GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer
: Biliary Tract Cancer
: 2014-06-28
:
  • Drug: Gemcitabine/Cisplatin Ge
Recruiting : MEK162 in Combination With Capecitabine in Advanced Biliary Tract Cancer
: Biliary Tract Cancer
: 2016-05-13
: Drug: MEK162+capecitabine In phase 1 part: capecitabine(mg/m2) will be given twice a day, 2 week on/1wee
Recruiting : A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer
: Unresectable Biliary Tract Cancer
: 2015-12-14
: Drug: nab-paclitaxel in combination with gemcitabine + cisplatin Patients with unresectable BTC will be
Next >>>